12:00 AM
Jun 22, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Prucalopride: Phase I data

Pooled data from the double-blind Phase I GBR-9 and GBR-10 trials in 32 and 24 healthy volunteers, respectively, showed that Resolor resulted in no clinically relevant...

Read the full 107 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >